← Leaderboards
Amit Praful Khandhar
Hdt Bio Corporation
$5,276,681
Attributed
$5,276,681
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,276,681 · 3
By mechanism
R61$2,913,796 · 1
R33$1,963,600 · 1
R43$399,285 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Engineering”
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
- John E West · University Of Texas At Austin$131,399,667
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Joy Williamson-Lott · University Of Washington$69,987,326
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$62,539,586
Research focus
EngineeringFormulationNanoparticleWashingtonProteinsLeadImmuneLipidsSqualeneViralUniversitiesTechnologyDropsBindingDesignComplementAntibodiesComplexAdjuvantAnimalsClinical TrialsCollaborationsCell MaturationAntigens
Grant awards (6)
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine$981,683
R33 · FY2025 · AI · contact PI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine$981,917
R33 · FY2024 · AI · contact PI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine$940,253
R61 · FY2023 · AI · contact PI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine$1,046,474
R61 · FY2022 · AI · contact PI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine$927,069
R61 · FY2021 · AI · contact PI
Targeting and Imaging Ovarian Cancer with Junction Opener Conjugated-Lipid Iron Oxide Nanoparticles (JOC-LIONs)$399,285
R43 · FY2021 · CA · contact PI